Display options
Share it on

J Nutr Sci. 2015 Apr 10;4:e12. doi: 10.1017/jns.2014.69. eCollection 2015.

Assessment of cardiometabolic risk in children in population studies: underpinning developmental origins of health and disease mother-offspring cohort studies.

Journal of nutritional science

R-C Huang, Susan L Prescott, Keith M Godfrey, Elizabeth A Davis

Affiliations

  1. Telethon Kids Institute , University of Western Australia , Roberts Road , Subiaco , WA , Australia ; 'In-FLAME' the International Inflammation Network , World Universities Network (WUN) ; Department of Endocrinology , Princess Margaret Hospital , Roberts Road , Subiaco , WA , Australia.
  2. Telethon Kids Institute , University of Western Australia , Roberts Road , Subiaco , WA , Australia ; 'In-FLAME' the International Inflammation Network , World Universities Network (WUN) ; School of Paediatrics and Child Health Research , University of Western Australia , Roberts Road , Subiaco , Australia.
  3. MRC Lifecourse Epidemiology Unit and NIHR Southampton Biomedical Research Centre , University of Southampton and University Hospital Southampton NHS Foundation Trust , Southampton , UK.
  4. Telethon Kids Institute , University of Western Australia , Roberts Road , Subiaco , WA , Australia ; Department of Endocrinology , Princess Margaret Hospital , Roberts Road , Subiaco , WA , Australia.

PMID: 26090093 PMCID: PMC4463019 DOI: 10.1017/jns.2014.69

Abstract

Pregnancy and birth cohorts have been utilised extensively to investigate the developmental origins of health and disease, particularly in relation to understanding the aetiology of obesity and related cardiometabolic disorders. Birth and pregnancy cohorts have been utilised extensively to investigate this area of research. The aim of the present review was twofold: first to outline the necessity of measuring cardiometabolic risk in children; and second to outline how it can be assessed. The major outcomes thought to have an important developmental component are CVD, insulin resistance and related metabolic outcomes. Conditions such as the metabolic syndrome, type 2 diabetes and CHD all tend to have peak prevalence in middle-aged and older individuals but assessments of cardiometabolic risk in childhood and adolescence are important to define early causal factors and characterise preventive measures. Typically, researchers investigating prospective cohort studies have relied on the thesis that cardiovascular risk factors, such as dyslipidaemia, hypertension and obesity, track from childhood into adult life. The present review summarises some of the evidence that these factors, when measured in childhood, may be of value in assessing the risk of adult cardiometabolic disease, and as such proceeds to describe some of the methods for assessing cardiometabolic risk in children.

Keywords: Cardiovascular risk; DOHaD, developmental origins of health and disease; DXA, dual-energy X-ray absorptiometry; IMT, intima media thickness; Metabolic disease; NAFLD, non-alcoholic fatty liver disease; PWV, pulse wave velocity; Paediatric health; Population studies; TNFR, TNF receptor

References

  1. J Intern Med. 1999 Jun;245(6):621-5 - PubMed
  2. Arch Intern Med. 1994 Aug 22;154(16):1842-7 - PubMed
  3. Pediatrics. 2005 Mar;115(3):e290-6 - PubMed
  4. Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):566-72 - PubMed
  5. J Clin Endocrinol Metab. 2002 Aug;87(8):3864-6 - PubMed
  6. Diabet Med. 2006 May;23(5):469-80 - PubMed
  7. Int J Pediatr Obes. 2010 Apr;5(2):122-9 - PubMed
  8. BJOG. 2006 Oct;113(10):1126-33 - PubMed
  9. Nutr Metab (Lond). 2011 Jan 20;8:3 - PubMed
  10. Arterioscler Thromb Vasc Biol. 2000 Sep;20(9):2070-5 - PubMed
  11. Int J Obes Relat Metab Disord. 2004 Jul;28(7):852-7 - PubMed
  12. Obesity (Silver Spring). 2009 Nov;17(11):2067-74 - PubMed
  13. Horm Res Paediatr. 2010;73(3):181-6 - PubMed
  14. Pediatrics. 2003 Jan;111(1):61-6 - PubMed
  15. Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1877-82 - PubMed
  16. Arterioscler Thromb Vasc Biol. 2002 Aug 1;22(8):1323-8 - PubMed
  17. Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76 - PubMed
  18. Eur J Epidemiol. 2007;22(12):917-23 - PubMed
  19. Am J Clin Nutr. 1993 May;57(5):605-8 - PubMed
  20. Int J Epidemiol. 2006 Feb;35(1):42-8 - PubMed
  21. Obes Rev. 2008 Sep;9(5):474-88 - PubMed
  22. Diabetes Care. 2009 Apr;32(4):695-701 - PubMed
  23. Lancet. 2005 Dec 3;366(9501):1954-9 - PubMed
  24. J Mol Med (Berl). 2001 Apr;79(2-3):109-15 - PubMed
  25. Am J Physiol Endocrinol Metab. 2000 Jul;279(1):E83-7 - PubMed
  26. Biol Chem. 2002 Oct;383(10):1581-5 - PubMed
  27. Diabetes. 2000 Dec;49(12):2208-11 - PubMed
  28. Horm Res. 2006;65 Suppl 3:65-9 - PubMed
  29. Curr Opin Lipidol. 2014 Feb;25(1):61-6 - PubMed
  30. Obesity (Silver Spring). 2007 Mar;15(3):760-71 - PubMed
  31. Diabetes. 2011 May;60(5):1528-34 - PubMed
  32. J Pediatr. 2008 Feb;152(2):160-4 - PubMed
  33. Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):775-82 - PubMed
  34. Clin Exp Allergy. 2004 Aug;34(8):1237-42 - PubMed
  35. Int J Obes Relat Metab Disord. 2003 Jul;27(7):755-77 - PubMed
  36. Int J Obes Relat Metab Disord. 2004 Apr;28(4):470-5 - PubMed
  37. Circulation. 2002 Jun 11;105(23):2712-8 - PubMed
  38. Am J Clin Pathol. 2001 Dec;116 Suppl:S108-15 - PubMed
  39. Pediatrics. 2006 Jul;118(1):165-72 - PubMed
  40. BMJ. 2012 Aug 30;345:e5605 - PubMed
  41. Hepatology. 2013 Oct;58(4):1306-14 - PubMed
  42. Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1268-73 - PubMed
  43. Circulation. 2003 Jan 28;107(3):391-7 - PubMed
  44. Gastroenterology. 2005 Jul;129(1):113-21 - PubMed
  45. Am J Clin Nutr. 1999 Nov;70(5):811-6 - PubMed
  46. Diabetes. 2000 Jun;49(6):1042-8 - PubMed
  47. J Clin Endocrinol Metab. 2012 Jun;97(6):E1014-22 - PubMed
  48. Development. 2000 Oct;127(19):4195-202 - PubMed
  49. Am J Epidemiol. 1991 May 1;133(9):884-99 - PubMed
  50. BMJ. 2000 Apr 8;320(7240):967-71 - PubMed
  51. Lancet. 2010 Jan 9;375(9709):132-40 - PubMed
  52. Br J Nutr. 2007 Jun;97(6):1064-73 - PubMed
  53. Diabetes Care. 2011 Apr;34(4):1019-25 - PubMed
  54. Placenta. 1996 Mar-Apr;17(2-3):169-72 - PubMed
  55. Eur Heart J. 2007 Apr;28(7):850-6 - PubMed
  56. Hepatology. 2011 Mar;53(3):800-9 - PubMed
  57. JAMA. 1990 Dec 19;264(23):3018-24 - PubMed
  58. Br J Prev Soc Med. 1977 Jun;31(2):91-5 - PubMed
  59. Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19351-6 - PubMed
  60. Int J Obes (Lond). 2007 Feb;31(2):236-44 - PubMed
  61. J Pediatr Endocrinol Metab. 2005 Jan;18(1):75-82 - PubMed
  62. J Physiol. 2004 Dec 1;561(Pt 2):355-77 - PubMed
  63. Ann Nutr Metab. 2013;63(1-2):120-30 - PubMed
  64. Clin Sci (Lond). 2007 Nov;113(10):409-16 - PubMed
  65. Am J Hypertens. 1995 Jul;8(7):657-65 - PubMed
  66. Circulation. 2002 Jul 2;106(1):24-30 - PubMed
  67. BMC Pregnancy Childbirth. 2011 Oct 26;11:79 - PubMed
  68. JAMA. 2002 Dec 4;288(21):2709-16 - PubMed
  69. Circulation. 2003 Nov 11;108(19):2317-22 - PubMed
  70. Pediatrics. 2005 Jan;115(1):22-7 - PubMed
  71. Am J Physiol Endocrinol Metab. 2008 Dec;295(6):E1401-8 - PubMed
  72. Am J Clin Nutr. 2007 Jul;86(1):33-40 - PubMed
  73. Am J Clin Nutr. 2002 Sep;76(3):653-8 - PubMed
  74. Diabetes. 1988 Dec;37(12):1595-607 - PubMed
  75. Diabetes. 2014 Jul;63(7):2528-37 - PubMed
  76. Int J Pediatr Obes. 2011 Jun;6(2-2):e271-82 - PubMed
  77. J Pediatr. 2011 Dec;159(6):971-4 - PubMed
  78. Metabolism. 2004 Jul;53(7):863-7 - PubMed
  79. J Clin Endocrinol Metab. 2007 Dec;92(12):4569-74 - PubMed
  80. Circulation. 2001 Dec 11;104(24):2943-7 - PubMed
  81. Lancet. 2001 Oct 27;358(9291):1400-4 - PubMed
  82. J Paediatr Child Health. 2011 Dec;47(12):911-7 - PubMed
  83. Proc Nutr Soc. 2009 Aug;68(3):306-20 - PubMed
  84. J Appl Physiol (1985). 1989 Feb;66(2):814-21 - PubMed

Publication Types

Grant support